Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Immunovant (NASDAQ: IMVT).The analyst commented, “Immunovant ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE